Stock Analysts’ Updated EPS Estimates for August, 23rd (ADRNY, AEL, ARD, ARDS, ARGX, ASOMY, ASV, BCML, BOXL, BPMUF)

Stock Analysts’ updated eps estimates for Friday, August 23rd:

Koninklijke Ahold (OTCMKTS:ADRNY) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Koninklijke Ahold Delhaize N.V. provides retail stores which offer food and non-food products primarily in the United States and Europe. The Company operates supermarkets, convenience stores, compact hypers, pick-up points and gasoline stations as well as specialty stores. Koninklijke Ahold Delhaize N.V., formerly known as Ahold N.V., is based in Zaandam, Netherlands. “

American Equity Investment Life (NYSE:AEL) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “American Equity Investment Life Holding Company, through its wholly-owned operating subsidiaries, is a full service underwriter of a broad line of annuity and insurance products, with a primary emphasis on the sale of fixed rate and index annuities. “

Ardagh Group (NYSE:ARD) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Ardagh Group S.A. provides metal and glass packaging solutions, producing packaging for food, beverage and consumer brands. Ardagh Group S.A. is based in Luxembourg. “

Aridis Pharmaceuticals (NASDAQ:ARDS) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Aridis Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the discovery and development of immunotherapy using fully human monoclonal antibodies to treat life-threatening infections. The company’s product pipeline consists of AR-301, AR-105, AR-101, AR-401, AR-201 and AR-501 which are in clinical stages. Aridis Pharmaceuticals, Inc. is based in San Jose, United States. “

argenx (NASDAQ:ARGX) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “argenx SE is a biopharmaceutical company. It focuses on developing antibody-based therapies for the treatment of autoimmune diseases and cancer. The company’s product pipeline consists of ARGX-113, ARGX-110 and ARGX-111 which are in clinical trials. argenx SE is based in Breda, the Netherlands. “

ASOS PLC/ADR (OTCMKTS:ASOMY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “ASOS Plc is an online fashion destination. It offers branded and own-branded product lines, including womenswear and menswear, footwear, accessories, jewelry and beauty and grooming products primarily through its Website, asos.com. The company operates primarily in the United Kingdom, France, Germany, Italy, Spain, Australia, the United States, Russia and China. ASOS Plc is based in London, United Kingdom. “

ASV (NASDAQ:ASV) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “ASV Holdings Inc. is a designer and manufacturer of compact construction equipment which consists of loader and skid steer loader equipment. It operates primarily in North America, Australia and New Zealand. ASV Holdings Inc. is based in Grand Rapids, United States. “

BayCom (NASDAQ:BCML) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “BayCom Corp provides commercial banking products and services to businesses and individuals. The company offers deposit products, loans, online banking, cash management and banking services. BayCom Corp, formerly known as Bay Commercial Bank, is based in Walnut Creek, California. “

Boxlight (NASDAQ:BOXL) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Boxlight Corporation is an educational technology development company. It offers interactive educational products which consist of software, classroom technologies, professional development and support services. Boxlight Corporation is headquartered in Lawrenceville, Georgia. “

Basilea Pharmaceutica (OTCMKTS:BPMUF) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Basilea Pharmaceutica Ltd. is a commercial stage biopharmaceutical company developing products that address the medical challenge of increasing resistance and non-response to current treatment options in the therapeutic areas of bacterial infections, fungal infections and cancer. With two commercialized drugs, the company is committed to discovering, developing and commercializing innovative pharmaceutical products to meet the medical needs of patients with serious and life-threatening conditions. “

Cameco (NYSE:CCJ) (TSE:CCO) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Cameco Corporation is one of the world’s largest uranium producers, a significant supplier of conversion services and one of two CANDU fuel manufacturers in Canada. Their competitive position is based on their controlling ownership of the world’s largest high-grade reserves and low-cost operations. Their uranium products are used to generate clean electricity in nuclear power plants around the world. They also explore for uranium in the Americas, Australia and Asia. Their shares trade on the Toronto and New York stock exchanges. Their head office is in Saskatoon, Saskatchewan. “

CELYAD SA/ADR (NASDAQ:CYAD) had its buy rating reaffirmed by analysts at William Blair. The analysts wrote, “We believe that the data readouts in the second half of the year will shed light into the clinical improvements with the Optimab process, allogeneic platform, and the impact of the preconditioning regimen at potentially clinically relevant doses with an eye toward selecting a Phase II (potentially registration enabling) study regimen in 2020. Celyad in June presented updated data from dose level 3 (3e9 cells given in three biweekly infusions) and initial data from cohort 10 (1e9 cells at a dense schedule of three CY AD-01 weekly infusions) of the THINK study at the European Hematology Association (EHA) 2019 meeting (EHA With CY AD-01 Dense Schedule and Preconditioning Regimens).””

VOLKSWAGEN AG/ADR (OTCMKTS:VWAGY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “VOLKSWAGEN-ADR is the largest automobile manufacturer in Europe. Their activities focus on the automotive market and they offer products and services along the entire automotive value chain. With nine independent brands, they are able to offer a unique range of models from the extremely efficient 3-litre car to the great sporting tradition of Bentley. While each of the brands has a distinct personality, it also benefits from its membership of the Volkswagen Group with its global manufacturing base “

Wandisco (OTCMKTS:WANSF) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “WANdisco plc involved in the development and provision of collaboration software. The Company offers active data replication which enables data editing to the cloud and on-premises data centers as well as provides data migration, disaster recovery and hybrid cloud solutions. It also offers cloud services, such as Amazon S3 active migrator, Google cloud active migrator, and Fusion hybrid cloud services as well as provides software maintenance services. WANdisco plc is based in Sheffield, the United Kingdom. “

WEIR GRP PLC/S (OTCMKTS:WEGRY) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “The Weir Group PLC provides engineering solutions. The company’s operating segment consists of Minerals, Oil & Gas and Flow Control. Oil & Gas segment provides products and service solutions to upstream, production, transportation, refining and related industries. Flow Control segment designs and manufactures valves and pumps. Minerals segment offers provision of slurry handling equipment and associated aftermarket support. It also provides specialist support services to the global power generation, industrial and oil and gas sectors. The Weir Group PLC is headquartered in Glasgow, the United Kingdom. “

Wendys (NASDAQ:WEN) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. Zacks Investment Research currently has $23.00 price target on the stock. According to Zacks, “Although shares of Wendy’s have slightly underperformed the industry in a year, it is expected to remain on growth trajectory, after posting better-than-expected earnings in the second quarter of 2019. Its earnings not only surpassed the Zacks Consensus Estimate but also grew 28.6% year over year, primarily favored by lower tax rate. Increase in adjusted EBITDA also boosted the reported quarter’s earnings. Revenues in the quarter grew on increased sales at company-operated restaurants. Menu innovation, increased investments in technology and reimaging of restaurants are expected to boost its traffic and drive sales in the months ahead. Moreover, the company’s international business is poised to be a long-term growth driver. However, higher labor and commodity costs along with capital spending may dent margins.”

Receive News & Ratings for Koninklijke Ahold Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Ahold and related companies with MarketBeat.com's FREE daily email newsletter.